<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02433275</url>
  </required_header>
  <id_info>
    <org_study_id>8/2014</org_study_id>
    <nct_id>NCT02433275</nct_id>
  </id_info>
  <brief_title>CHildhood ASthma and Environment Research Study - CHASER Study</brief_title>
  <official_title>CHildhood ASthma and Environment Research Study - CHASER Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stefania La Grutta, MD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;CHildhood ASthma and Environment Research study - CHASER study&quot; is an observational
      longitudinal study in outpatient clinic of Pediatric Allergology &amp; Pulmonology (PAP) of
      Respiratory Disease Research Center (RDRC) within the Institute of Biomedicine and Molecular
      Immunology (IBIM) of the National Research Council (CNR) of Palermo (RDRC-IBIM CNR), Italy.

      The first phase - transversal study will identify determinants of pediatric asthma control

      The second phase - longitudinal study (2 year follow-up), in patients with persistent asthma,
      will be focused on:

        -  predictors for asthma exacerbations and loss of control

        -  real life adherence to asthma therapy guidelines

        -  phenotypic characterization through the collection of saliva samples

        -  assessment of alterations and inflammatory changes in the nasal mucosa through nasal
           brushing

      Chaser Project is expected to improve the knowledge of pediatric asthma in patients with
      different level of control, identifying predictors for asthma exacerbations and loss of
      control.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Asthma control assessment</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measures from saliva samples</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measures from nasal brushing</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Asthmatic children of both sex aged 5-16 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma

        Exclusion Criteria:

          -  Not Asthma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefania La Grutta, MD</last_name>
    <phone>+39-091-6809680</phone>
    <email>stefania.lagrutta@ibim.cnr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giovanni Viegi, MD</last_name>
    <phone>+39-091-6809501</phone>
    <email>giovanni.viegi@ibim.cnr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of Biomedicine and Molecular Immunology, IBIM</name>
      <address>
        <city>Palermo</city>
        <zip>90146</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania La Grutta, MD</last_name>
      <phone>+390916809680</phone>
    </contact>
    <contact_backup>
      <last_name>Giovanni Viegi, MD</last_name>
      <phone>+390916809501</phone>
      <email>giovanni.viegi@ibim.cnr.it</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2015</study_first_submitted>
  <study_first_submitted_qc>April 29, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy</investigator_affiliation>
    <investigator_full_name>Stefania La Grutta, MD</investigator_full_name>
    <investigator_title>Stefania La Grutta, MD. Senior Researcher. Coordinator of Pediatric Allergy and Asthma Research Group. Institute of Biomedicine and Molecular Immunology, IBIM, National Research Council of Palermo, Italy.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The IPD collected will be available on December 2020.
The following participant data will be shared:
Asthma severity level
Asthma control level
Pulmonary function tests
Demographic characteristics All IPD will be obtained from statistical analysis on the dedicated database in which all data are stored.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

